Rankings
▼
Calendar
MNKD (MannKind Corporation) Stock Financials & Earnings | Market Cap Arena
MNKD
MannKind Corporation
Mkt Cap
$813M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$349M
Net Income (TTM)
$6M
EPS (TTM)
$0.02
Free Cash Flow (TTM)
$14M
Gross Margin
76.4%
Op. Margin
11.1%
Net Margin
1.7%
FCF Margin
3.9%
P/S Ratio (TTM)
2.3x
P/E Ratio (TTM)
138.7x
YoY Rev Growth
+22.2%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$41M
$24M
-$6M
Q2 23
$49M
$34M
$2M
Q3 23
$51M
$37M
$5M
Q4 23
$58M
$40M
$8M
Q1 24
$66M
$48M
$17M
Q2 24
$72M
$52M
$17M
Q3 24
$70M
$52M
$13M
Q4 24
$77M
$57M
$26M
Q1 25
$78M
$61M
$22M
Q2 25
$77M
$56M
$5M
Q3 25
$82M
$62M
$19M
Q4 25
$112M
$88M
-$8M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
6.3x
—
Q2 23
5.1x
—
Q3 23
4.6x
—
Q4 23
4.1x
—
Q1 24
3.6x
95.8x
Q2 24
3.3x
69.3x
Q3 24
3.0x
37.7x
Q4 24
2.8x
29.5x
Q1 25
2.7x
27.0x
Q2 25
2.7x
24.8x
Q3 25
2.6x
27.8x
Q4 25
2.3x
138.7x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$1M
-$7M
Q2 23
$3M
-$14M
Q3 23
$9M
-$3M
Q4 23
$22M
$16M
Q1 24
$7M
$4M
Q2 24
$4M
$861K
Q3 24
$9M
$8M
Q4 24
$23M
$20M
Q1 25
-$6M
-$7M
Q2 25
$9M
$8M
Q3 25
$23M
$22M
Q4 25
-$8M
-$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$8M
Q2 23
$17M
Q3 23
$11M
Q4 23
$6M
Q1 24
$2M
Q2 24
$3M
Q3 24
$1M
Q4 24
$3M
Q1 25
$330K
Q2 25
$1M
Q3 25
$1M
Q4 25
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+238.8%
+40.2%
Q2 23
+157.3%
+19.2%
Q3 23
+56.1%
+8.8%
Q4 23
+62.2%
+3.6%
Q1 24
+63.1%
+6.3%
Q2 24
+48.9%
+19.0%
Q3 24
+36.7%
+24.2%
Q4 24
+31.3%
-0.7%
Q1 25
+18.2%
+13.2%
Q2 25
+5.7%
+27.7%
Q3 25
+17.2%
+10.5%
Q4 25
+45.8%
+137.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$4M
9.0%
Q2 23
$6M
11.5%
Q3 23
$5M
9.0%
Q4 23
$4M
6.5%
Q1 24
$4M
5.9%
Q2 24
$6M
8.9%
Q3 24
$5M
7.5%
Q4 24
$6M
7.6%
Q1 25
$5M
6.9%
Q2 25
$8M
9.8%
Q3 25
$0
0.0%
Q4 25
$7M
6.2%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$6M
$11M
$13M
—
Q2 23
$6M
$12M
$14M
—
Q3 23
$10M
$11M
$13M
—
Q4 23
$9M
$10M
$11M
—
Q1 24
$10M
$11M
$12M
—
Q2 24
$12M
$13M
$11M
—
Q3 24
$13M
$11M
$13M
—
Q4 24
$11M
—
—
$24M
Q1 25
$11M
—
—
$25M
Q2 25
$14M
—
—
$32M
Q3 25
$14M
$14M
$15M
—
Q4 25
$28M
—
—
$58M
marketcaparena.com
Revenue Segments
License And Service
Product
Royalty
Product Revenue
Service
Quarter
License And Service
Product
Royalty
Product Revenue
Service
Q2 24
$26M
$21M
$26M
—
—
Q3 24
$23M
$20M
$27M
—
—
Q1 25
$29M
$19M
$30M
—
—
Q2 25
—
—
$31M
$45M
$621K
Q3 25
—
—
$33M
$48M
$537K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$86M
$80M
$166M
Q2 23
$86M
$58M
$144M
Q3 23
$83M
$58M
$141M
Q4 23
$238M
$57M
$295M
Q1 24
$193M
$107M
$301M
Q2 24
$97M
$151M
$248M
Q3 24
$62M
$189M
$252M
Q4 24
$46M
$151M
$197M
Q1 25
$47M
$134M
$182M
Q2 25
$57M
$122M
$179M
Q3 25
$127M
$133M
$260M
Q4 25
$75M
$96M
$171M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
264M
+0.2%
Q2 23
266M
+0.6%
Q3 23
269M
+1.2%
Q4 23
324M
+20.5%
Q1 24
325M
+0.3%
Q2 24
273M
-15.9%
Q3 24
285M
+4.3%
Q4 24
291M
+2.1%
Q1 25
321M
+10.4%
Q2 25
311M
-2.9%
Q3 25
312M
+0.0%
Q4 25
314M
+0.8%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
287
FY 15
$0
192
FY 16
$1M
153
FY 17
$47K
250
FY 18
$124K
225
FY 19
$271K
233
FY 20
$270K
241
FY 21
$216K
349
FY 22
$253K
395
FY 23
$481K
414
FY 24
$701K
407
FY 25
$589K
592
marketcaparena.com